INVEGA HAFYERA™ The First & Only Long-Acting Injectable (LAI) That Can Be Given Twice Yearly To Adult Patients With Schizophrenia Who Have Been Adequately Treated With INVEGA SUSTENNA® or INVEGA TRINZA®
Sponsored By Janssen
The life expectancy of people with serious mental illness is lower than for the non-SMI population. While many factors contribute to these findings, we also know that addressing modifiable risks for people in this category can moderate those findings. In this presentation, after we hear directly from Janssen, the attendees will then discuss the role that long acting anti-psychotic medications can play in an integrated care plan that focuses on management of complex physical health issues.
Please enjoy warm pretzels and a selection of dipping sauces during this session!